Forms of apremilast
US10730836B2 · kind B2 · utility
0Cited by
6References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 29, 2019 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Aug 29, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure is directed to novel forms of apremilast and pharmaceutical compositions comprising any of the novel forms of apremilast. Also provided are processes for the preparation of novel forms of apremilast.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.